About
Eric Roeland, MD, is a medical oncologist and palliative care specialist. His clinical practice focuses on caring for patients with melanoma and patients with cancer participating in early phase clinical trials. Dr. Roeland’s research focuses on symptom science to improve treatment tolerance and quality of life of patients with symptomatic cancer by identifying, validating, and expanding pharmacologic interventions. Dr. Roeland is a proud husband and father of three children. Outside of work, he prioritizes time with his family and exploring the outdoors.
Key Accomplishments
- Member, Adult Cancer Pain Panel, National Comprehensive Cancer Network (2013-2018)
- Member, Antiemesis Panel, NCCN (2013-2021)
- Lead author, ASCO Guideline Management of Cancer Cachexia [PMID: 32432946]
- Co-Chair, ASCO Supportive Care Guidelines (2018-2021)
- Co-Chair, ASCO Supportive Care in Oncology Symposium Planning Committee (2019)
- Member, ASCO International Education Steering Committee (2019 – Present)
- Member, ASCO Evidence-based Guidelines Committee (2021 – Present)
- Member, Precision Promise Supportive Care Committee, Pancreatic Cancer Action Network (2021 – Present)
- Associate Editor, Supportive Care in Cancer (2021 – Present)
Education / Honors
- American Academy of Hospice and Palliative Medicine (AAHPM), Inspirational Leader Under 40 Award, 2015
- ASCO Education Scholars Program, 2018-2019
- Massachusetts General Physicians OrganizationBrian A McGovern, MD Award for Clinical Excellence Nominee, 2019, 2021
- Massachusetts General Hospital, Top Oncology Internal Medicine Education Nominee, 2020
- Fellow, AAHPM, 2009
- Internship and Residency, University of California San Diego, 2005-2008
- Fellow, Hospice and Palliative Medicine, San Diego Hospice and The Institute for Palliative Medicine, 2008-2009
- Fellow, Hematology and Oncology, University of California San Diego, 2009-2012
Please Leave a Review or Suggestion